INDOLINONE AND CHEMOTHERAPEUTIC AGENT COMBINED ADMINISTRATION IN CONDITIONS, CAUSED BY CELL PROLIFERATION

摘要

FIELD: medicine; oncology. ^ SUBSTANCE: versions of method include combined administration of 5-(5-fluoro-2-oxo-1,2-dihydroindole-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrol-3-carboxylic acid (2-diethylaminoethyl)amide and docetaxel in low doses that are ineffective in single-drug therapy. ^ EFFECT: synergistic anti-tumour effect, lowered doses of each drug. ^ 2 cl, 8 dwg, 8 tbl,24 ex